Category Archives: Life Sciences

Subscribe to Life Sciences RSS Feed

How Big Pharma Taps Outside Ingenuity

Economics in getting a compound approved and commercialized are evolving. Drug companies have reduced budgets that historically funded vast R&D teams. Innovators are chasing tight investment dollars. The two camps are increasingly collaborating. There is a self-selection factor rewarding start-ups — they can’t attract funding or licensing deals unless they’ve protected their intellectual property, showed clinically … Continue Reading

Greenberg Traurig to Sponsor Two Major Israel Event

Greenberg Traurig will be sponsoring two major Israel events this coming week. The first is the OurCrowd Global Investor Summit (January 25-26), set to bring together 3,000 investors and companies from 50 different countries. Shareholder and Israel Practice Co-Chair, Bob Grossman will be speaking at the opening planery. Israel Practice Co-Chairan, Tel-Aviv Managing Shareholder, and Global Corporate & Securities Practice Senior … Continue Reading

GT Events during the 2016 JPMorgan Healthcare Conference & the 9th Annual OneMedForum in San Francisco

Innovation and progress are core ingredients in today’s financial ecosystem, especially in the fields of health care and life sciences.  Greenberg Traurig has a renowned healthcare practice, serving many clients in Israel and abroad.  Greenberg Traurig will be hosting two events in January during the 2016 JPMorgan Healthcare Conference and the 9th Annual OneMedForum in … Continue Reading

Ingenuity in Israel’s Water

Israel is a garden of inventiveness and Israelis have a strong tradition of contributing to technology and life sciences. Breathing the innovation when I lived there, I was privileged to test PrimeSense’s 3D camera, help bring Notal Vision’s tool to gauge macular degeneration to the United States, deliver a turn-key VoIP network in Nigeria and Zambia … Continue Reading

Greenberg Traurig Assists Israeli Company in Raising Capital in the US

Joining a number of companies listed on the Tel Aviv Stock Exchange that also have recently been listed for trading in the United States through American Depository Receipts (ADRs) is universal flu vaccine developer BiondVax Pharmaceuticals Ltd. The company raised $10 million on Nasdaq at a price of $5.01 per American Depositary Share (ADS). ADRs are … Continue Reading

Greenberg Traurig Co-Sponsoring IATI Biomed 2015

Israel Advanced Technology Industries (IATI) is Israel’s largest non-profit umbrella organization for the high-tech and life science sectors. Greenberg Traurig is an IATI  member and is co-sponsoring the organization’s flagship event, IATI Biomed 2015, taking place May 12-14 at the Tel Aviv Fairgrounds. Thousands of industry players, engineers, and scientists are expected to attend the convention and … Continue Reading

Greenberg Traurig to Host Presentation: ‘Trends in the Israeli Life Sciences Arena’

Greenberg Traurig’s Boston office will be hosting a breakfast presentation entitled “Trends in the Israeli Life Sciences Arena” featuring guest speaker Elka Nir from Israel.  The event is scheduled for 8-9:45 a.m. on Friday, April 24, 2015, with welcome remarks at 8:30 a.m. by David Dykeman, co-chair of Greenberg Traurig’s Life Sciences & Medical Technology Group, … Continue Reading

New England Executives Get an Inside Look at Israeli Innovation

Israel is home to more than 750 medical device companies, 300 pharmaceutical/biotech companies, and 170 other life science or healthcare IT companies. David Dykeman, co-chair of Greenberg Traurig’s  Life Science & Medical Technology Group, describes Israel as a “biomedical and healthcare powerhouse.” David recently led a delegation of New England executives and investors from the … Continue Reading

Greenberg Traurig Attorneys Participate in J.P. Morgan Healthcare Conference & Biotech Showcase

The 33rd Annual J.P. Morgan Healthcare Conference & Biotech Showcase was held in January in San Francisco, Calif. The conference is the biggest health care investing event of the year, attracting thousands of medical device, biotechnology, and pharmaceutical executives and investors in attendance from around the world. Numerous Israeli companies participated in the conference, including a … Continue Reading
LexBlog